Subscribe to our newsletter! Stay always in touch!
Nothing on this website or any associated links should be considered financial advice. Always consult a qualified financial, tax, or accounting professional before making any financial decisions.
Disclaimer: The information provided by The People’s Economist (TPE) in our financial calculators and dashboards is for general informational purposes only and is not intended to provide specific financial or investment advice. The calculations provided by these tools are based on certain assumptions that may vary with your specific circumstances. Though TPE does our best to assure the accuracy of our calculators, we make certain simplifying assumptions in some cases and the results of the financial calculators are not guaranteed and are not a substitute for professional financial advice. Users should seek the advice of a finance professional before making any financial decisions. Though we do our best to ensure the accuracy of the calculators, TPE is not responsible for any errors or omissions, or for any action taken in reliance on information contained on this website. TPE expressly disclaims all liability in respect of any actions taken or not taken based on any contents of this website. By using TPE financial calculators and dashboards, you agree to hold TPE harmless from any and all losses, liabilities, or expenses incurred as a result of using the information provided. The use of TPE Website and its contents does not create a client relationship with TPE. TPE may update or modify this disclaimer at any time without prior notice. By continuing to use TPE’s financial calculators after any changes to this disclaimer, you accept and agree to any and all modifications. Please contact us with any questions or concerns about this disclaimer or its use of financial calculators
Settlement resolves thousands of US lawsuits, with a record UK case against the company under way.
Johnson & Johnson (J&J) has agreed to pay $5.5bn to settle tens of thousands of lawsuits in the United States that allege its discontinued talc-based baby powder caused ovarian cancer.
The pharmaceutical giant made the announcement on Monday, saying it covers about 69,000 cases in US federal and state courts, accounting for 99.75 percent of outstanding talc-related cases in the country.
The settlement will only be final once it is accepted by 95 percent of the claimants in state or federal courts.
Talc is a soft mineral and was once a staple ingredient in cosmetics and baby products, but its use has declined as concerns rose over its links to cancer.
In 2024, the World Health Organization classified talc as “probably carcinogenic to humans”.
J&J maintains that there is no evidence that talc causes cancer, but it stopped selling talc-based baby powder in the US in 2020 and worldwide in 2023.
In 2016, a US jury ordered J&J to pay $72m to the family of a woman who died of ovarian cancer, the first such case related to the use of the mineral in the country.
Though the case was overturned a year later, claims against the company have multiplied since, with juries across the US awarding the plaintiffs.
Erik Haas, J&J’s litigation head, said the agreement lets J&J “put this matter behind it”.
Lawyers representing the plaintiffs welcomed the settlement as a good resolution to a decade-long court battle.
The deal does not cover the United Kingdom, where the largest product liability case in UK history – covering more than 7,000 potential claimants – is being adjudicated.
Advertisement
Filed in October 2025, the UK case alleges that J&J knew that its talc could cause cancers, chiefly ovarian and mesothelioma, but continued to sell the product, a claim the company also denies.
The case has since gone before the UK High Court.
